Novo Nordisk | Aktywa



Assets Zmiana Data
ANI Pharmaceuticals USD 1.34B 50.57M 2025-06
Aurora Cannabis CAD 866.52M 57.75M 2024-12
Bausch Health Companies USD 27.27B 845M 2025-06
Bristol-Myers Squibb USD 94.68B 2.25B 2025-06
Canopy Growth CAD 1.16B 68.13M 2024-12
Corcept Therapeutics USD 801.72M 44.73M 2025-06
Drreddys Laboratories INR 481.06B 15.1B 2024-12
Eli Lilly USD 100.92B 11.53B 2025-06
GlaxoSmithKline GBP 59.26B 1.45B 2025-06
Merck USD 117.52B 2.4B 2025-06
Novartis USD 104.4B 4.45B 2025-06
Novo Nordisk 482.15B 7.01B 2025-06
Novo Nordisk DKK 489.16B 91.72B 2025-03
Pacira USD 1.54B 49.41M 2025-06
Perrigo USD 10.09B 334.3M 2025-06
Prestige Brands USD 3.43B 29.41M 2025-06
Sanofi 124.96B 6.93B 2025-06
Supernus Pharmaceuticals USD 1.38B 35.11M 2025-06
Zoetis USD 14.48B 381M 2025-06


Novo Nordisk Aktywa - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - Aug 2025.